(Q36388380)

13 August 2017

1 reference

title

Animal models for the study of HBV replication and its variants (English)

1 reference

13 August 2017

Dandri M

1

1 reference

13 August 2017

Volz TK

series ordinal

2

1 reference

13 August 2017

Lütgehetmann M

series ordinal

3

1 reference

13 August 2017

Petersen J

series ordinal

4

1 reference

13 August 2017

language of work or name

1 reference

1 December 2005

1 reference

Journal of Clinical Virology

13 August 2017

published in

1 reference

13 August 2017

volume

34 Suppl 1

1 reference

13 August 2017

page(s)

S54-62

1 reference

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Transmission of Type B Viral Hepatitis to Chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Calcium signaling by HBx protein in hepatitis B virus DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepatitis B viruses and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepatitis B viruses and cancerogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

HBV and HDV replication in experimental models: effect of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

A new avian hepadnavirus infecting snow geese (Anser caerulescens) produces a significant fraction of virions containing single-stranded DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

A transgenic mouse model of the chronic hepatitis B surface antigen carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

In vitro experimental infection of primary human hepatocytes with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Virion DNA of ground squirrel hepatitis virus: structural analysis and molecular cloning

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Loss and acquisition of duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Double-stranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

High-level hepatitis B virus replication in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepadnavirus infection in captive gibbons

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepatitis B virus transgenic mouse model of chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Lamivudine therapy of WHV-infected woodchucks.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepatitis C virus replication in mice with chimeric human livers

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Woodchuck hepatitis virus: experimental infection and natural occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Properties of recombinant hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Replacement of diseased mouse liver by hepatic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

The woodchuck: an animal model for hepatitis B virus infection in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

The replication cycle of hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: implications for an origin of HBV.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Functional inactivation but not structural mutation of p53 causes liver cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Cloned HBV DNA causes hepatitis in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Human hepatocytes transplanted into genetically immunocompetent rats are susceptible to infection by hepatitis B virus in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Human hepatitis B virus and hepatocellular carcinoma I. Experimental infection of tree shrews with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980011-3

7 January 2021

10.1016/S1386-6532(05)80011-3

Identifiers

DOI

1 reference

13 August 2017

1 reference